MGGPX
Price
$36.74
Change
+$0.07 (+0.19%)
Updated
Jun 5 closing price
Net Assets
3.39B
RNPGX
Price
$67.37
Change
-$0.25 (-0.37%)
Updated
Jun 5 closing price
Net Assets
150.13B
Interact to see
Advertisement

MGGPX vs RNPGX

Header iconMGGPX vs RNPGX Comparison
Open Charts MGGPX vs RNPGXBanner chart's image
Morgan Stanley Inst Global Opp A
Price$36.74
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets3.39B
American Funds New Perspective R6
Price$67.37
Change-$0.25 (-0.37%)
VolumeN/A
Net Assets150.13B
MGGPX vs RNPGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGGPX vs. RNPGX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGGPX is a Buy and RNPGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 150B vs. MGGPX (3.39B). RNPGX pays higher dividends than MGGPX: RNPGX (0.82) vs MGGPX (0.00). MGGPX was incepted earlier than RNPGX: MGGPX (15 years) vs RNPGX (16 years). MGGPX (1.22) is less costly to investors than RNPGX (0.41). RNPGX is a more actively managed with annual turnover of: 24.00 vs. MGGPX (19.00). RNPGX has a lower initial minimum investment than MGGPX: RNPGX (250) vs MGGPX (1000). MGGPX annual gain was more profitable for investors over the last year : 19.84 vs. RNPGX (9.61). RNPGX return over 5 years is better than : 45.22 vs. MGGPX (16.19).
MGGPXRNPGXMGGPX / RNPGX
Total Expense Ratio1.220.41298%
Annual Report Gross Expense Ratio1.220.41298%
Fund Existence15 years16 years-
Gain YTD12.7968.801145%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.39B150B2%
Annual Yield % from dividends0.000.82-
Returns for 1 year19.849.61206%
Returns for 3 years38.2230.23126%
Returns for 5 years16.1945.2236%
Returns for 10 years134.7679.85169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOVX0.470.01
+2.84%
Theriva Biologics Inc
KROS15.110.29
+1.96%
Keros Therapeutics
GLNG41.820.60
+1.46%
Golar Lng Ltd
GLSI9.360.02
+0.21%
Greenwich LifeSciences
PODD317.16-2.05
-0.64%
Insulet Corp